BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19966502)

  • 1. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
    Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
    Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
    Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
    Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
    Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
    J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.
    Sunagawa Y; Morimoto T; Takaya T; Kaichi S; Wada H; Kawamura T; Fujita M; Shimatsu A; Kita T; Hasegawa K
    J Biol Chem; 2010 Mar; 285(13):9556-9568. PubMed ID: 20081228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?
    Araujo CM; Hermidorff MM; Amancio Gde C; Lemos Dda S; Silva ME; de Assis LV; Isoldi MC
    J Recept Signal Transduct Res; 2016 Oct; 36(5):435-44. PubMed ID: 27305962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
    Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
    J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
    Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
    PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.
    Hu X; Li T; Zhang C; Liu Y; Xu M; Wang W; Jia Z; Ma K; Zhang Y; Zhou C
    J Cell Mol Med; 2011 Sep; 15(9):1865-77. PubMed ID: 20874724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of Targeted Pharmacotherapy for Cardiovascular Disease].
    Katanasaka Y
    Yakugaku Zasshi; 2017; 137(11):1349-1353. PubMed ID: 29093370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
    Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.
    Li T; Liu Z; Hu X; Ma K; Zhou C
    Biochim Biophys Acta; 2012 Feb; 1823(2):582-92. PubMed ID: 22227582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin.
    Davidson SM; Townsend PA; Carroll C; Yurek-George A; Balasubramanyam K; Kundu TK; Stephanou A; Packham G; Ganesan A; Latchman DS
    Chembiochem; 2005 Jan; 6(1):162-70. PubMed ID: 15593114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
    Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
    Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.
    Tsai CF; Yang SF; Chu HJ; Ueng KC
    Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
    Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
    Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac p300 is involved in myocyte growth with decompensated heart failure.
    Yanazume T; Hasegawa K; Morimoto T; Kawamura T; Wada H; Matsumori A; Kawase Y; Hirai M; Kita T
    Mol Cell Biol; 2003 May; 23(10):3593-606. PubMed ID: 12724418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
    Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
    J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
    Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
    J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.